Table 4.
Combined effects of risk alleles of missense SNPs in each pathway
Pathway | No. of risk alleles | Cases (%) | Controls (%) | OR (95% CI) | P, trend |
---|---|---|---|---|---|
BER | 3–5 | 58 (24.5) | 102 (21.7) | 1.00 | |
6 | 88 (37.1) | 152 (32.3) | 1.00 (0.66 – 1.52) | ||
7 | 64 (27.0) | 142 (30.1) | 0.80 (0.52 – 1.24) | ||
8–9 | 27 (11.4) | 75 (15.9) | 0.63 (0.36 – 1.09) | ||
Per allele | 0.88 (0.76 – 1.02) | 0.09 | |||
| |||||
NER | 5– 9 | 93 (39.2) | 190 (40.3) | 1.00 | |
10 | 57 (24.1) | 96 (20.4) | 1.21 (0.80 – 1.84) | ||
11 | 41 (17.3) | 102 (21.7) | 0.82 (0.53 – 1.28) | ||
12–16 | 46 (19.4) | 83 (17.6) | 1.16 (0.74 – 1.80) | ||
Per allele | 1.01 (0.92 – 1.11) | 0.83 | |||
| |||||
DSB-HR | 3–5 | 74 (31.2) | 138 (29.3) | 1.00 | |
6 | 67 (28.3) | 145 (30.8) | 0.86 (0.57 – 1.30) | ||
7 | 46 (19.4) | 107 (22.7) | 0.80 (0.51 – 1.25) | ||
8–12 | 50 (21.1) | 81 (17.2) | 1.15 (0.73 – 1.81) | ||
Per allele | 0.99 (0.89 – 1.11) | 0.84 | |||
| |||||
DSB-NHEJ | 2–3 | 31 (13.1) | 96 (20.4) | 1.00 | |
4 | 179 (75.5) | 329 (69.9) | 1.69 (1.08 – 2.64) | ||
5–6 | 27 (11.4) | 46 (9.8) | 1.92 (1.02 – 3.60) | ||
Per allele | 1.37 (1.03 – 1.82) | 0.03 | |||
| |||||
MMR | 2–4 | 82 (34.6) | 188 (39.9) | 1.00 | |
5 | 72 (30.4) | 114 (24.2) | 1.47 (0.99 – 2.18) | ||
6 | 46 (19.4) | 87 (18.5) | 1.23 (0.79 – 1.92) | ||
7–10 | 37 (15.6) | 82 (17.4) | 1.03 (0.65 – 1.65) | ||
Per allele | 1.07 (0.96 – 1.18) | 0.22 | |||
| |||||
DNA Polymerase | 3–4 | 38 (16.0) | 70 (14.9) | 1.00 | |
5 | 89 (37.6) | 179 (38.0) | 0.92 (0.57 – 1.47) | ||
6 | 95 (40.1) | 172 (36.5) | 1.01 (0.63 – 1.62) | ||
7–8 | 15 (6.3) | 50 (10.6) | 0.55 (0.27 – 1.11) | ||
Per allele | 0.94 (0.78 – 1.13) | 0.50 | |||
| |||||
0–3 | 70 (29.5) | 130 (27.6) | 1.00 | ||
Fanconi Anemia groups | 4 | 96 (40.5) | 197 (41.8) | 0.88 (0.60 – 1.29) | |
5 | 59 (24.9) | 119 (25.3) | 0.91 (0.59 – 1.39) | ||
6 | 12 (5.1) | 25 (5.3) | 0.86 (0.40 – 1.82) | ||
Per allele | 0.97 (0.83 – 1.14) | 0.69 |